T cell receptor

Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma 2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard • 6 Apr 2022
Developing individualized cancer therapies with neoantigen-specific TCRs 4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard • 6 Apr 2022
Improving immune-imaging tools to assess cancer immunotherapies 5:33
Improving immune-imaging tools to assess cancer immunotherapies
Angela Krackhard • 6 Apr 2022
Targeting WT1 peptides for TCR-based AML therapy 2:04
Targeting WT1 peptides for TCR-based AML therapy
Chiara Bonini • 1 Apr 2022
TCR redirected T cells for cancer therapy 1:46
TCR redirected T cells for cancer therapy
Chiara Bonini • 1 Apr 2022
Characterization of ATA188: an off-the-shelf therapy for MS 4:08
Characterization of ATA188: an off-the-shelf therapy for MS
Jakob Dupont • 17 Jun 2021
PD1-41BB switch receptor expression in the treatment of PD-L1-positve solid tumors 5:11
PD1-41BB switch receptor expression in the treatment of PD-L1-positve solid tumors
Dolores Schendel • 25 Feb 2021
The content of VJRegenMed is intended for healthcare professionals